共 196 条
[1]
Perera M(2016)Sensitivity, specificity, and predictors of positive 68 ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis Eur Urol 70 926-937
[2]
Papa N(2018)68 Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: Impact on salvage radiotherapy planning J Nucl Med 59 230-237
[3]
Christidis D(2016)(68)ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer : early efficacy after primary therapy Strahlenther Onkol 192 431-439
[4]
Wetherell D(2019)Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review Eur Urol 76 493-504
[5]
Hofman MS(2017)Radiotherapy as metastasis-directed therapy for oligometastatic prostate cancer Curr Opin Urol 27 587-595
[6]
Murphy DG(2011)[18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes Radiat Oncol 6 44-84192
[7]
Calais J(2017)Salvage lymph node dissection after (68)Ga-PSMA or (18)F-FEC PET/CT for nodal recurrence in prostate cancer patients Oncotarget 8 84180-557
[8]
Czernin J(2016)68 Ga-PSMA positron emission tomography/computed tomography provides accurate staging of lymph node regions prior to lymph node dissection in patients with prostate cancer Eur Urol 70 553-739
[9]
Cao M(2016)(68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment BJU Int 117 732-429
[10]
Kishan AU(2019)Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer Strahlenther Onkol 195 420-654